InspireMD Inc. - Common Stock (NSPR)
1.3500
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 18th, 9:35 PM EDT
Detailed Quote
| Previous Close | 1.350 |
|---|---|
| Open | 1.340 |
| Bid | 1.330 |
| Ask | 1.420 |
| Day's Range | 1.320 - 1.390 |
| 52 Week Range | 1.280 - 2.932 |
| Volume | 145,506 |
| Market Cap | 57.20M |
| PE Ratio (TTM) | -1.627 |
| EPS (TTM) | -0.8 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 49,863 |
Chart
About InspireMD Inc. - Common Stock (NSPR)
InspireMD Inc is a medical device company that specializes in developing innovative solutions for the treatment of cardiovascular diseases. Its primary focus is on providing advanced stent technologies that enhance the treatment of vascular conditions, primarily through its proprietary MGuard stent platform. This platform utilizes a unique design that incorporates a polymeric mesh to protect the vascular walls during and after procedures, aiming to improve patient outcomes and reduce complications. The company's commitment to research and development underpins its mission to offer groundbreaking products that address unmet medical needs in the field of interventional cardiology and vascular care. Read More
News & Press Releases
InspireMD (NSPR) Q3 2025 results beat revenue estimates by 40%, driven by the successful U.S. launch of its CGuard Prime carotid stent system.
Via Chartmill · November 4, 2025
ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of Raymond W. Cohen to its Board of Directors.
By RxSight, Inc. · Via GlobeNewswire · August 4, 2025
Via Benzinga · August 1, 2025
Via Benzinga · July 31, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 24, 2025

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via Benzinga · November 6, 2023
The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets.
Via Stocktwits · May 9, 2025

Via Benzinga · December 3, 2024

NSPR stock results show that InspireMD missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024

NSPR stock results show that InspireMD missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024

NSPR stock results show that InspireMD beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024

Via Benzinga · August 23, 2023

Via Benzinga · July 21, 2023

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via Benzinga · March 6, 2024
